Sanofi: concludes alliance with Boaster
(CercleFinance.com) - After trading on Thursday Sanofi announced that it has concluded an alliance with the French Institute of technological research in microbiology - BIOASTER - to improve the search for a new generation of candidate vaccines.
This aims to identify the molecular signatures of immunogenicity and safety, thanks to the systems biology using the techniques "multi-omics".
Sanofi said that through this partnership with Bioaster, and its input of new technological platforms, it will now be possible to bring the understanding of these action mechanisms to a level of molecular and cellular granularity and precision that it has not yet been possible to reach.
Copyright (c) 2017 CercleFinance.com. All rights reserved.
This aims to identify the molecular signatures of immunogenicity and safety, thanks to the systems biology using the techniques "multi-omics".
Sanofi said that through this partnership with Bioaster, and its input of new technological platforms, it will now be possible to bring the understanding of these action mechanisms to a level of molecular and cellular granularity and precision that it has not yet been possible to reach.
Copyright (c) 2017 CercleFinance.com. All rights reserved.